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Monday, February 22, 2010 291a(565KKKRRK570) immediately following helix 8 in the c-terminus of M3R
was found to be necessary for the decrease in Gq-V mobility. We tested the
hypothesis that an electrostatic interaction was involved in the interaction
between M3Rs and Gq by repeating our FRAP experiments in permeabilized
cells exposed to buffer solutions with high and low ionic strength. High ionic
strength solutions inhibited the decrease in Gq mobility, whereas low ionic
strength solutions enhanced this effect. These results suggest that an electro-
static interaction mediates an interaction between the c-terminus of M3Rs and
Gq heterotrimers. The functional significance of this interaction is currently
under study.
Supported by grant GM078319 from the National Institutes of Health.
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Hundreds of G-protein coupled receptors (GPCR) are encoded in the human
genome. All GPCRs react to a vast variety of ligands and initiate the G-protein
activation cycle, by catalyzing the exchange of GDP by GTP on the Ga sub-
unit. Classically, this mode of activation has been proposed to be of catalytic
collision coupling nature, where a single receptor sequentially activates sev-
eral G-proteins. However, recent biophysical and imaging studies challenged
this concept and suggested that some GPCR and G-proteins form stable non-
dissociating complexes prior to and after activation. We were interested in
determining the mode of coupling between the human muscarinic 2 receptor
(m2R) and Gai3bg. We used the G-protein activated Kþ channel (GIRK)
as a reporter for receptor activation and systematically quantified receptor’s
and channel’s plasma membrane concentrations using fluorescent methods
and radioligand assays. We found a decrease in activation time at high recep-
tor density, with no change in channel concentration. However, maximal am-
plitude was attained at lower receptor density, suggesting an amplification
process. No change in Gbg concentration was observed, as judged by the un-
changed Gbg-dependent basal activity of GIRK. Additionally, increasing
amounts of m2R did not increase Gai concentration. Together, these results
suggest a catalytic collision coupling mechanism. We constructed a model de-
scribing m2R’s activation scheme and predicted that excessive Ga subunits
should slow the activation process by occupying the activated receptor in
‘‘dead-end’’ interactions, not leading to channel activation. Increasing
amounts of two fluorescent Gai3 subunits were used to test the prediction.
Indeed, both subunits slowed the evoked-current, without change in current
amplitude. These results, together with our previous observations, suggest
that the m2R activates Gai3 via a catalytic collision coupling mechanism,
where one receptor diffuses and activates several Gabg subunits, leading to
the activation of GIRK.
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Binding of a-factor pheromone to the G-protein coupled receptor, Ste2p,
initiates signal transduction events that lead to mating of the yeast Saccharo-
myces cerevisiae. Recent indirect evidence also implicates the N-terminal
region of Ste2p in modulating cell wall degradation and membrane fusion
during later steps of mating. Toward deciphering mechanisms, structural stud-
ies have been initiated on the N-terminus of Ste2p. Initially, residues 1-71 of
Ste2p were expressed as a fusion protein with HIS and KSI tags and affinity
purified from E.coli in mg quantities. Subsequent cyanogens bromide cleavage
at methionines yielded a hydrophobic peptide (Ste2p 2-54) that consistently
disappeared upon HPLC enrichment. Similarly, a chemically synthesized frag-
ment corresponding to Ste2p residues 14-43 could not be purified by HPLC.
However, the addition of three lysines to both termini was found to decrease
hydrophobicity sufficiently to enable HPLC purification. Circular dichroism
studies of a chemically synthesized K3-Ste2p-14-43-K3 peptide indicated
mostly random structure, with ~45% b-strand and a small percentage of a-he-
lix in buffered water. The structure was found to be stable at temperatures up
to 40C. These results correlate with predicted 2o structure for the Ste2p
N-terminal domain including: random chain with a b-strand-loop-b-strand
fold followed by a C-terminal a-helix (Shi et al., J. Cell. Biochem.
107:630-38) and recent NMR evidence suggesting a-helix in a C-terminal
overlapping region (residues 39-47; Neumoin et al., 2009 Biophysical Journal
96: 3187-96). Preliminary 1H-1H NOESY and TOCSY NMR data for theK3-Ste2p 14-43-K3 peptide have been collected. As well, a recombinant
version of K3-Ste2p-2-43-K3 is being produced to extend the N-terminal
region to be analyzed and facilitate isotopic labeling for complete structural
elucidation.
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Termination of G protein-coupled receptor (GPCR) signaling typically in-
volves phosphorylation of the receptor, followed by binding of a protein called
arrestin. Here we tested the minimal stoichiometry required for this inter-
action, by determining if a single rhodopsin molecule can bind arrestin. To
do this, we prepared nanoscale phospholipids particles, so-called nanodiscs,
which contain only monomeric rhodopsin and measured their ability to bind
visual arrestin. Our data clearly show that visual arrestin can bind to mono-
meric phosphorylated rhodopsin to stabilize its active form, called metarho-
dopsin II. Interestingly, we find beta-arrestin can also bind to monomeric
rhodopsin in nanodiscs and stabilize metarhodopsin II. Together, these results
suggest that in general, the minimal unit for arrestin binding is a monomeric
GPCR.
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The receptor dimers that mediate bacterial chemotaxis form signaling com-
plexes with CheW and the kinase CheA. Based on the packing arrangement ob-
served in two different crystal structures of two different receptor cytoplasmic
fragments, two different models have been proposed for receptor signaling
arrays: the trimers-of-dimers and hedgerow models. We have identified an
inter-dimer distance predicted to be substantially different by the two models,
labeled the atoms defining this distance through isotopic enrichment, and mea-
sured it with 19F-13C REDOR. This was done in two types of receptor samples:
isolated bacterial membranes containing overexpressed, intact receptor, and
soluble receptor fragments reconstituted into kinase-active signaling com-
plexes. In both cases, the distance found was incompatible with both the
trimers-of-dimers and the hedgerow models. Comparisons of simulated and
observed REDOR dephasing were used to deduce a closest-approach distance
at this interface, which provides a constraint for the possible arrangements of
receptor assemblies in the kinase-
active signaling state.
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The introduction of unique chemical groups into proteins by means of site-
directed mutagenesis with unnatural amino acids has numerous applications
in protein engineering and functional studies. We first introduced p-acetyl-L-
phenylalanine (Acp) or p-azido-L-phenylalanine (Azp) into the prototypical
G protein-coupled receptor (GPCR) rhodopsin at specific sites. We employed
an amber codon suppression system where the mutant opsin gene was co-
expressed with the appropriate
orthogonal pair of engineered tRNA
and amino-acyl tRNA synthetase.
We then used hydrazone (hydrazide)
or Staudinger-Bertozzi (phosphine)
ligation chemistry for the keto group
(in Acp) or azido group (in Azp),
respectively, to link a fluorophore at
various solvent accessible sites in
rhodopsin. In side-by-side compari-
sons of the two chemical ligation
chemistries, which were carried out
292a Monday, February 22, 2010under physiological conditions where receptor function is maintained, we con-
clude that the azido group serves as a more satisfactory chemical handle than
the keto moiety. The fully-functional fluorescently-labeled receptor should
prove useful for kinetic studies of ligand-receptor interaction.
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We describe a general application of the nonsense suppression methodology
for unnatural amino acid incorporation in functional G protein-coupled recep-
tors (GPCRs). We have evaluated key aromatic residues in the binding sites
of the M2 muscarinic acetylcholine receptor and the D2 and D4 dopamine
receptors. In addition, highly conserved transmembrane proline residues of
the D2 dopamine receptor have been probed with proline analogues and a-hy-
droxy acids. Receptors were expressed in Xenopus oocytes, and activation of
a G protein-coupled, inward-rectifying Kþ channel (GIRK) provided, after
optimization of conditions, a quantitative readout of receptor function. Incorpo-
ration of a series of fluorinated tryptophan derivatives at W6.48 of the D2
receptor establishes a cation-p interaction between the agonist dopamine and
W6.48, suggesting a reorientation of W6.48 on agonist binding, consistent
with proposed ‘‘rotamer switch’’ models. Interestingly, no comparable cat-
ion-p interaction was found at the aligning residue in the M2 receptor. Incor-
poration of a-hydroxy acids at transmembrane proline sites 4.59, 5.50, 6.50,
and 7.50 yielded D2 receptors with EC50 values similar to wild-type, whereas
natural amino acids other than proline proved detrimental to receptor function.
We propose that lack of hydrogen bond donor ability, common to both proline
and a-hydroxy acids, is key to the functional role of proline within GPCR trans-
membrane helices.
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Functional and structural studies on GPCR are ideally conducted on single,
protein-carrying bilayers with unrestricted access for ligands and G-proteins.
It is desirable to have a large accessible surface area and protection from
a solid support. Reconstitution of GPCR into bilayers supported by porous an-
odic aluminum oxide (AAO) nanopores meets those requirements. Extrusion
of proteoliposomes through the nanopores resulted in formation of tubules
of a single lipid bilayer that covers the inner surface of pores. We successfully
reconstituted the GPCRs rhodopsin and recombinant peripheral cannabinoid
receptor CB2 at functional conditions and high concentration into the cylindri-
cal AAO nanopores with a diameter of 200 nm and a length of 60 mm. One
square centimeter of AAO filter yielded 500 cm2 of membrane surface. The
lipid tubules are open at both ends such that buffer passes easily through
the pores. Detergents used for protein reconstitution are flushed out within
minutes. By 2H NMR we demonstrated that neither lipid headgroups nor hy-
drocarbon chains of fluid bilayers are perturbed by the solid support. Photoac-
tivation of rhodopsin in the pores, monitored by UV-vis spectrophotometry,
was indistinguishable from rhodopsin in unsupported liposomes. Metarhodop-
sin-II in the tubules activated G-protein that was delivered through the pore
openings. By NMR diffusion experiments we determined that tubular bilayers
are assembled as short pieces with a length of a micrometer or less that adhere
to the surface by their edges. The tubules possess undulation with a radius of
curvature of 100-400 nm. We have evidence for a layer of water with an
average thickness of 3 nm between the bilayers and the pore surface. It ex-
plains why neither protein function nor fluid bilayer properties are perturbed
by the solid support.1526-Pos
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C-C chemokine receptor 5 (CCR5) is a G protein-coupled receptor (GPCR)
involved in immune responses and it is the primary co-receptor required for
HIV-1 cellular entry. To obtain functional heterologous over-expression of
engineered GPCRs is one of the major hurdles in GPCR research aimed at elu-
cidating structure-activity relationships. It can be especially difficult to obtain
structural information about GPCRs in signaling complexes with other cellular
proteins that form a so-called ‘‘signalosome.’’ We have developed two new
technologies for investigating the structure and function of GPCRs, which
we have now applied to CCR5. First, we have established a membrane nano-
particle system called NABBs (nanoscale apolipoprotein bound bilayers),
which are self-assembling discs that maintain receptors in a native-like mem-
brane environment outside of the cell. We have incorporated functional
CCR5 into NABBs and plan to use this platform to reconstitute the ternary
complex with chemokine ligand and G protein from purified components. In
addition, we have adapted unnatural amino acid mutagenesis for use with
GPCRs. This is a method to incorporate amino acids with unique side chains
at specific sites in the receptor. We introduced p-benzoyl-L-phenylalanine,
into CCR5 at various positions on both the extracellular and intracellular
surface of the protein using the amber suppression technology. Since the ben-
zoyl moiety is a photo-activatable crosslinker, these mutants can now be used
to map the specific sites of interaction between ligand, receptor, and G pro-
tein as predicted from molecular modeling and molecular dynamics simula-
tions. Our methods will form the basis of a new experimental paradigm in
the structural biology of signaling complexes on a mesoscopic level. Ulti-
mately, these methods will be useful for developing a chemically-precise
model for how an extracellular ligand stimulates a GPCR to activate a cyto-
solic G protein.
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Molecularly targeted therapies are at the forefront of clinical science, and are
expected to lead to personalization of medical treatments for each patient.
Most such therapies are directed at inhibiting specific signal transduction en-
zymes or pathways, thus creating a critical need for assays capable of measur-
ing the activities of these proteins in disease models and in patient samples.
The ability to measure relevant enzyme activity in primary cell samples at
baseline and/or after treatment would provide the ability to tailor patient ther-
apy based on aberrant signal transduction, validate mechanisms of resistance
in patients, and would offer an invaluable pharmacodynamic tool to assess
whether resistance is associated with inadequate target inhibition. Here we
report our current efforts to create the analytical and chemical tools needed
to directly measure the enzymatic activities of therapeutic targets including
protein kinases, lipid modifying enzymes and the proteasome. Fluorescent
reagents are under development that report the activity of these various en-
zymes in model cells lines and primary cells. The basic design incorporates
enzyme substrates that are modified to create compounds which can be loaded
into cells where they are modified by the enzyme of interest. Work has in-
cluded modification of peptides to confer membrane permeability and to
achieve long intracellular lifetimes. Microelectrophoretic separations com-
bined with low-level fluorescence detection enable the quantitative analysis
of these compounds from single mammalian cells. This capability addresses
three major issues currently faced in the biochemical analysis of clinical sam-
ples: the need for direct measurement of the enzymatic activity of target
proteins; sample size requirements that are feasible for clinical implementa-
tion; and sample heterogeneity that can mask pertinent aspects related to ther-
apeutic response.
